Anti-vascular Endothelial Growth Factor Treatment of Retinopathy of Prematurity: Efficacy, Safety, and Anatomical Outcomes
Hyun Goo Kang, Eun Young Choi, Suk Ho Byeon, Sung Soo Kim, Hyoung Jun Koh, Sung Chul Lee, Min Kim
Korean J Ophthalmol. 2018;32(6):451-458.   Published online 2018 Nov 27     DOI: https://doi.org/10.3341/kjo.2018.0011
Citations to this article as recorded by Crossref logo
Ursodeoxycholic Acid Halts Pathological Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy
Menaka C. Thounaojam, Ravirajsinh N. Jadeja, Shubhra Rajpurohit, Diana R. Gutsaeva, Brian K. Stansfield, Pamela M. Martin, Manuela Bartoli
Journal of Clinical Medicine.2020; 9(6): 1921.     CrossRef
Gene Therapy Intervention in Neovascular Eye Disease: A Recent Update
Fan-Li Lin, Peng-Yuan Wang, Yu-Fan Chuang, Jiang-Hui Wang, Vickie H.Y. Wong, Bang V. Bui, Guei-Sheung Liu
Molecular Therapy.2020; 28(10): 2120.     CrossRef
Refractive Outcomes of 4-Year-old Children after Intravitreal Anti-vascular Endothelial Growth Factor versus Laser Photocoagulation for Retinopathy of Prematurity
Hyun Goo Kang, Tae Young Kim, Jinu Han, Sueng-Han Han
Korean Journal of Ophthalmology.2019; 33(3): 272.     CrossRef